Martin George Kelly
SEC insider (Form 3/4/5 filer). CIK 0001982607. Director at TriSalus Life Sciences, Inc. (TLSI). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 28, 2024. Located in WESTMINSTER, CO.
Companies Martin George Kelly has filed insider reports for
- TriSalus Life Sciences, Inc. (TLSI): Director
Martin George Kelly
CIK: 0001982607
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLSI
TriSalus Life Sciences, Inc.
Director